FEMA550030

HMBS Recombinant Rabbit Monoclonal Antibody (8G12), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 FEMA550030-Each-of-1 In Stock ₹ 37,202.00

FEMA550030 - Each of 1

₹ 37,202.00

In Stock

Quantity

1

Base Price: ₹ 37,202.00

GST (18%): ₹ 6,696.36

Total Price: ₹ 43,898.36

Antigen

HMBS

Classification

Recombinant Monoclonal

Concentration

0.67 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide, pH 7.4

Gene Accession No.

P08397

Gene Symbols

Hmbs

Immunogen

A synthesized peptide derived from human HMBS

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Form

Liquid

Applications

ELISA, Western Blot

Clone

8G12

Conjugate

Unconjugated

Gene

Hmbs

Gene Alias

alternative name: porphobilinogen deaminase, HEM3, hemC, HMBS, Hydroxymethylbilane synthase, PBG D, PBGD, PBG-D, PORC, Porphobilinogen deaminase, porphyria, acute, Chester type, pre-uroporphyrinogen synthase, similar to Porphobilinogen deaminase (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase) (PBG-D), T25658, Ups, uroporphyrinogen I synthase, uroporphyrinogen I synthetase, URO-S, Uros1

Host Species

Rabbit

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

3145

Content And Storage

-20°C or -80°C if preferred

Isotype

IgG

Related Products

Img

Thermo Scientific

FEMA550046

--

Img

Thermo Scientific

FEMA550062

--

Img

Thermo Scientific

FEMA550036

--

Img

Thermo Scientific

FEMA550184

--

Img

Thermo Scientific

FEMA550132

--

Img

Thermo Scientific

FEMA549884

--

Img

Thermo Scientific

FEMA549962

--

Img

Thermo Scientific

FEMA550109

--

Description

  • PBGD (porphobilinogen deaminase), also designated hydroxymethylbilane synthase, is a cytoplasmic enzyme found in the heme synthesis pathway
  • PBGD belongs to the HMBS (hydroxymethylbilane synthase) family
  • Deficiency of PBGD causes errors in pyrrole metabolism, which in turn leads to an inherited autosomal disorder called acute intermittent porphyria (AIP)
  • AIP is characterized by acute attacks of neurological dysfunctions with hypertension, tachycardia, peripheral neurologic disturbances, abdominal pain and excessive amounts of aminolevulinic acid and porphobilinogen in the urine.